A Multimodal Theranostic Nanoformulation That Dramatically Enhances Docetaxel Efficacy Against Castration Resistant Prostate Cancer
Author:
Funder
The Kaleida Health Foundation
Publisher
Elsevier BV
Subject
Pharmaceutical Science
Reference26 articles.
1. Advances in the treatment of metastatic prostate cancer;Park;Mayo Clin Proc,2015
2. Prostate cancer;Weiner;Med Clin North Am,2018
3. Metastatic castration-resistant prostate cancer: new therapies, novel combination strategies and implications for immunotherapy;Drake;Oncogene,2014
4. Docetaxel plus prednisone or mitoxantrone plus prednisone for advanced prostate cancer;Tannock;N Engl J Med,2004
5. Castration resistant prostate cancer: role of chemotherapy;Bilusic,2019
Cited by 11 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. The influence of various polymer coatings on the in vitro and in vivo properties of PLGA nanoparticles: Comprehensive study;European Journal of Pharmaceutics and Biopharmaceutics;2024-08
2. PLGA nanomedical consignation: A novel approach for the management of prostate cancer;International Journal of Pharmaceutics;2024-03
3. Nanoconjugates and nanoconjugate formulations for improving drug delivery and therapeutic efficacy;Advanced Nanoformulations;2023
4. Poly(lactic acid) and poly(lactic-co-glycolic acid)-based nanocarrier systems for theranostic applications;Polymeric Nanosystems;2023
5. Nanotherapeutic Approach to Delivery of Chemo- and Gene Therapy for Organ-Confined and Advanced Castration-Resistant Prostate Cancer;Critical Reviews™ in Therapeutic Drug Carrier Systems;2023
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3